Overview

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder

Status:
COMPLETED
Trial end date:
2024-11-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of toludesvenlafaxine hydrochloride sustained-release tablets in the treatment of major depression disorder compared to venlafaxine hydrochloride sustained-release tablets, to provide evidence-based basis for clinical rational drug use.
Phase:
NA
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University